Atea Pharmaceuticals to Present Positive Clinical Data with At-527 for the Treatment of Chronic Hepatitis C in Patients with Cirrhosis at The Liver Meeting ® 2018

World News: . []

BOSTON Nov 09 2018 GLOBE NEWSWIRE -- Atea Pharmaceuticals Inc a biopharmaceutical company engaged in the development of next-generation therapeutics for the treatment of hepatitis C and other single stranded RNA viral infections today ann ounced ...

More news and information about Atea Pharmaceuticals, Inc.

Published By:

Globe Newswire: 13:01 GMT Friday 9th November 2018

Published: .

Search for other references to "atea" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us